Search

Your search keyword '"Maintenance treatment"' showing total 1,266 results

Search Constraints

Start Over You searched for: Descriptor "Maintenance treatment" Remove constraint Descriptor: "Maintenance treatment"
1,266 results on '"Maintenance treatment"'

Search Results

1. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort.

2. Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study.

3. Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines.

4. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases.

5. Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program.

6. Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.

7. Real-world effectiveness of long-acting injectable vs. oral antipsychotics in patients with bipolar I disorder: a 1-year retrospective observational study.

8. Meta-analysis of effectiveness and safety of proteasome inhibitor-dependent maintenance treatment for multiple myeloma a systematic review

9. Naltrexone

11. Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image study.

12. Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001.

13. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

14. Best practices in the treatment of melasma with a focus on patients with skin of color.

15. Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive‐stage small‐cell lung cancer patients (DURABLE study)

16. Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma

17. Key questions on the long term renal effects of lithium: a review of pertinent data

18. Patient and Physician Preferences for Acute Myeloid Leukemia Maintenance Treatments Following Hematopoietic Stem Cell Transplantation

20. A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

21. Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive‐stage small‐cell lung cancer patients (DURABLE study).

22. Key questions on the long term renal effects of lithium: a review of pertinent data.

23. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment‐resistant schizophrenia receiving clozapine: A 1‐year retrospective cohort study.

24. Enhancing panic disorder treatment with mobile-aided case management: an exploratory study based on a 3-year cohort analysis.

25. Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States

26. Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis

27. Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States.

28. S-I maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis.

29. Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAFV600E mutation status.

30. Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients

31. Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trialResearch in context

32. Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma.

33. Real‐world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis.

34. Mood Stabilizers of First and Second Generation.

35. Blood pressure and heart rate in aripiprazole once -- monthly and paliperidone 1 and 3-month long-acting preparations.

36. TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma

37. Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients.

38. Application of Antipsychotic Drugs in Mood Disorders.

39. Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer.

40. Polyangéite microscopique.

41. Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China.

42. Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.

43. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials.

44. ECT‐related anxiety during maintenance ECT: A prospective study.

45. Effect of long-acting injectable antipsychotics on emergency department visits and hospital admissions in people with bipolar disorder: A retrospective mirror-image analysis from the Northern Milan Area Cohort (NOMIAC) study.

46. TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.

47. Impact of opioid maintenance therapy in the community on re-incarceration in individuals with opioid use disorder—A linked cohort study.

48. Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study

49. Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.

50. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

Catalog

Books, media, physical & digital resources